BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jachs M, Hartl L, Schaufler D, Desbalmes C, Simbrunner B, Eigenbauer E, Bauer DJM, Paternostro R, Schwabl P, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Trauner M, Mandorfer M, Reiberger T. Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes. Gut 2021;70:1758-67. [PMID: 33199442 DOI: 10.1136/gutjnl-2020-322712] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Debnath P, Rathi P. Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease. J Hepatol 2021;74:999-1000. [PMID: 33340583 DOI: 10.1016/j.jhep.2020.11.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Costa D, Simbrunner B, Reiberger T. Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease". J Hepatol 2021;74:1000-1. [PMID: 33497763 DOI: 10.1016/j.jhep.2021.01.026] [Reference Citation Analysis]
3 Wang YJ, Zhu YB, Wei WJ. Effect of non-selective β-receptor blockers on inflammatory factors and prognosis in advanced chronic liver disease. Shijie Huaren Xiaohua Zazhi 2021; 29(19): 1110-1117 [DOI: 10.11569/wcjd.v29.i19.1110] [Reference Citation Analysis]
4 Ambrosini YM, Piedra-Mora C, Jennings S, Webster CRL. Serum 25-hydroxyvitamin D and C-reactive protein concentrations and von Willebrand factor activity in 23 dogs with chronic hepatopathies. J Vet Intern Med 2022. [PMID: 35420222 DOI: 10.1111/jvim.16424] [Reference Citation Analysis]
5 Simbrunner B, Costa D, Reiberger T. Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease". J Hepatol 2021;75:234-6. [PMID: 33852949 DOI: 10.1016/j.jhep.2021.03.027] [Reference Citation Analysis]
6 Jachs M, Hartl L, Simbrunner B, Bauer D, Paternostro R, Scheiner B, Schwabl P, Stättermayer AF, Pinter M, Eigenbauer E, Quehenberger P, Trauner M, Reiberger T, Mandorfer M. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00726-6. [PMID: 34256145 DOI: 10.1016/j.cgh.2021.07.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pomej K, Balcar L, Scheiner B, Semmler G, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib. J Hepatocell Carcinoma 2021;8:1485-93. [PMID: 34877268 DOI: 10.2147/JHC.S317957] [Reference Citation Analysis]
8 Semmler G, Reiberger T. Letter to Lavian and colleagues. Eur J Radiol 2021;134:109449. [PMID: 33309458 DOI: 10.1016/j.ejrad.2020.109449] [Reference Citation Analysis]
9 Scheiner B, Balcar L, Johanna Nussbaumer R, Weinzierl J, Paternostro R, Simbrunner B, Hartl L, Jachs M, Bauer D, Stättermayer AF, Semmler G, Pinter M, Ay C, Quehenberger P, Trauner M, Reiberger T, Lisman T, Mandorfer M. Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2021.12.038] [Reference Citation Analysis]
10 Nathwani R, Kockerling D, Mullish BH, Cole A, Lemoine M, Antoniades CG, Thursz MR, Dhar A. Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections. Frontline Gastroenterol 2022;13:86-8. [PMID: 34970431 DOI: 10.1136/flgastro-2021-101818] [Reference Citation Analysis]
11 Jachs M, Hartl L, Bauer D, Simbrunner B, Stättermayer AF, Strassl R, Trauner M, Mandorfer M, Reiberger T. Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression. JPM 2022;12:239. [DOI: 10.3390/jpm12020239] [Reference Citation Analysis]
12 Ferstl P, Trebicka J. Acute Decompensation and Acute-on-Chronic Liver Failure. Clin Liver Dis 2021;25:419-30. [PMID: 33838858 DOI: 10.1016/j.cld.2021.01.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis. World J Hepatol 2021; 13(7): 731-746 [PMID: 34367495 DOI: 10.4254/wjh.v13.i7.731] [Reference Citation Analysis]
14 Balcar L, Semmler G, Pomej K, Simbrunner B, Bauer D, Hartl L, Jachs M, Paternostro R, Bucsics T, Pinter M, Trauner M, Mandorfer M, Reiberger T, Scheiner B. Patterns of acute decompensation in hospitalized patients with cirrhosis and course of acute-on-chronic liver failure. United European Gastroenterol J 2021;9:427-37. [PMID: 34050619 DOI: 10.1002/ueg2.12089] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Jachs M, Reiberger T, Mandorfer M. Reply. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00908-3. [PMID: 34454102 DOI: 10.1016/j.cgh.2021.08.028] [Reference Citation Analysis]
16 Mandorfer M, Reiberger T, Jachs M. Reply. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00923-X. [PMID: 34487886 DOI: 10.1016/j.cgh.2021.08.043] [Reference Citation Analysis]